Brand and generic drug manufacturers frequently settle patent litigation on terms that include a payment to the generic manufacturer along with a specified date at which the generic would enter the market. The Federal Trade Commission contends that these agreements extend the brand's market...

Brand and generic drug manufacturers frequently settle patent litigation on terms that include a payment to the generic manufacturer along with a specified date at which the generic would enter the market. The Federal Trade Commission contends that these agreements extend the brand's market...

We study how two distinct types of pre-entry experience - core technological experience and market-based complementary experience - affect post-entry performance in a new industry. We focus on the fit between capabilities generated through pre-entry experience and the preferences of...